Results 91 to 100 of about 37,549 (151)

Reply to Liao <i>et al.</i>: Optimizing Levofloxacin Dosing for Multidrug-resistant Tuberculosis in Low-Fat-Free Mass Asian Populations. [PDF]

Am J Respir Crit Care Med
Phillips PPJ, Peloquin CA, Sterling TR, Mitnick CD, Horsburgh CR.   +4 more
europepmc   +1 more source

Multidrug-resistant tuberculosis involving breast and adnexa uteri: a case report and literature review. [PDF]

BMC Infect Dis
Cui XY, He GQ, Shi JC, Huang YT, Lin ZR, Wu LP, Jiang XG.   +6 more
europepmc   +1 more source

Multidrug-Resistant Tuberculosis [PDF]

, 2020
openaire   +1 more source

Interim efficacy and safety analysis of the regimen containing delamanid in the treatment of multidrug resistant/rifampicin-resistant/extensively drug-resistant tuberculosis: a single-arm, prospective, monocentric, observational study. [PDF]

BMC Infect Dis
Qin Y, Chen Y, Cai Q.
europepmc   +1 more source

Epidemiologic trajectories and burden of multidrug-resistant tuberculosis (MDR-TB) mortality across South Asia: An analysis of Global Burden of Disease data (1990-2023) with machine learning forecasting to 2050. [PDF]

J Clin Tuberc Other Mycobact Dis
Khalil I, Abrar S, Khalid Reza IM, Hossain MI, Akter MM, Sultana F.   +5 more
europepmc   +1 more source

The burden of tuberculosis and drug resistance in 22 Sub-Saharan African countries, 1990-2021: a GBD 2021 analysis and progress towards WHO 2035 targets with projections to 2050. [PDF]

Front Microbiol
Li S, Mensah E, Liu M, Pan L, Lu W, Zhou S, Zhang L, Cheng Y, Zhao H, Wei S, Zha L.   +10 more
europepmc   +1 more source

Impact of the COVID-19 Pandemic on Drug-Resistant Tuberculosis in Europe: A Meta-Analysis of Epidemiological Trends. [PDF]

Pharmaceuticals (Basel)
Zouganeli C, Toubanaki DK, Karaoulani O, Vrioni G, Karagouni E, Efstathiou A.   +5 more
europepmc   +1 more source

Global burden of HIV and drug-resistant tuberculosis co-infection and its attributable risk factors, 1990 to 2021, with projections to 2031. [PDF]

BMC Infect Dis
Feng L, Wang Y, Li L, Wang X, Feng J.
europepmc   +1 more source

Optimizing Levofloxacin Dosing for Multidrug-resistant Tuberculosis in Low-Fat-Free Mass Asian Populations. [PDF]

Am J Respir Crit Care Med
Liao R, Guo J, Feng Y.
europepmc   +1 more source

Characterization of Drug Resistance Patterns, Mutation Profiles and Prevalence of <i>Mycobacterium tuberculosis</i> in Shaoxing. [PDF]

Infect Drug Resist
Zhao J, Mao W, Jin F, Xu W.
europepmc   +1 more source